HYTN Innovations Inc. announced that it has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand (Promethean) pursuant to the Company's supply agreement (the Agreement) with TCann Pty Ltd. (TCann).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 CAD | +2.94% | 0.00% | +400.00% |
1st Jan change | Capi. | |
---|---|---|
+400.00% | 19.3M | |
+8.32% | 271B | |
+4.46% | 46.59B | |
+14.27% | 22.89B | |
-12.60% | 16.73B | |
+16.70% | 12.55B | |
+21.70% | 11.22B | |
+4.84% | 11.15B | |
+5.24% | 9.21B | |
+50.33% | 6.32B |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- HYTN Grows Exports with Cannabis Flower Sales to Australia